AU Patent

AU2024204213B2 — Dosing regimens associated with extended release paliperidone injectable formulations

Assigned to Janssen Pharmaceutica NV · Expires 2026-02-26 · 0y expired

What this patent protects

4813-6202-2375.1 The present invention provides a method of treating patients with long acting injectable paliperidone palmitate formulations.

USPTO Abstract

4813-6202-2375.1 The present invention provides a method of treating patients with long acting injectable paliperidone palmitate formulations.

Drugs covered by this patent

Patent Metadata

Patent number
AU2024204213B2
Jurisdiction
AU
Classification
—
Expires
2026-02-26
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Pharmaceutica NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.